On 19 and 21 February, Director Emily Walden will speak in the session “Preparing for Antitrust Scrutiny of Health Care Transactions in 2025” at the American Health Law Association’s Advising Providers: Legal Strategies for AMCs, Physicians, and Hospitals conference. She will discuss the increasing scrutiny on healthcare mergers and acquisitions, the impact of new state and federal regulations, and best practices for navigating evolving antitrust requirements. The session will cover legislative activity affecting healthcare transactions, the challenges of roll-up strategies, and considerations for market concentration and compliance.